000 01291 a2200337 4500
005 20250512151859.0
264 0 _c19680807
008 196808s 0 0 eng d
022 _a0022-2623
024 7 _a10.1021/jm00309a018
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBaker, B R
245 0 0 _aIrreversible enzyme inhibitors. CXIX. Active-site-directed irreversible inhibitors of dihydrofolic reductase with tissue specificity derived from 2,4,6-triaminopyrimidine with a terminal sulfonyl fluoride at the 5 position.
_h[electronic resource]
260 _bJournal of medicinal chemistry
_cMay 1968
300 _a489-94 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aBinding Sites
650 0 4 _aCarcinoma 256, Walker
_xenzymology
650 0 4 _aFluorides
_xchemical synthesis
650 0 4 _aFolic Acid Antagonists
650 0 4 _aLeukemia L1210
_xenzymology
650 0 4 _aLiver
_xenzymology
650 0 4 _aMice
650 0 4 _aPyrimidines
_xchemical synthesis
650 0 4 _aRats
650 0 4 _aSulfonic Acids
_xchemical synthesis
700 1 _aMeyer, R B
773 0 _tJournal of medicinal chemistry
_gvol. 11
_gno. 3
_gp. 489-94
856 4 0 _uhttps://doi.org/10.1021/jm00309a018
_zAvailable from publisher's website
999 _c5243235
_d5243235